Legend Biotech (ä¼ å„ēē©) IPO Trading: +27% Upside from Pricing
Legend Biotech, a leading CAR-T player, priced at USD 23/ADS and raised USD 423 million. The stock will start trading today. In this note, we will...
498 Views
Legend Biotech IPO: Pass on Valuation
Legend Biotech (LEGN US)Ā is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
519 Views
Legend Biotech (ä¼ å„ēē©) Pre-IPO: A Good Deal for the Promising CAR-T
Legend Biotech, a subsidiary of Hong Kong-listed GenScript, started book building to raise up to USD 368 million via an IPO. The company has a...
441 Views
ECM Weekly (31 May 2020) - JD & NetEase HK, Legend Biotech, Burning Rock, Dada Nexus, Kangji
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. As per...
461 Views
Legend Biotech (ä¼ å„ēē©) Pre-IPO: Superior Efficacy Vs Bluebird/BMS Candidate
Legend Biotech, a subsidiary of Hong Kong-listed GenScript, is planning to raise up to USD 300 million via an IPO. The company has a strong focus...
456 Views